
Simple to set up and use. Get your results in 5 seconds.
The smartLIGHT feature provides you with an instant indicator of your blood glucose results so you know whether they are within (green), above (amber), or below (red) your target range.1
The CONTOUR®NEXT ONE system met the minimum accuracy requirements of the ISO 15197:2013 standard* 2,3
Second-Chance® sampling allows you to reapply more blood to the same test strip when the first sample is not enough,1 to help you waste fewer strips4
The free CONTOUR DIABETES app is available to support diabetes self-management, adding insight and meaning to the results
Easy to use: Syncs** automatically with the meter to upload all blood glucose readings to an electronic diary
Easy to understand: My Patterns helps identify trends in blood glucose results and sends notifications of potential causes
Easy to share: The blood sugar diary report can be sent prior to, or shared during, an appointment with the healthcare professional
Check to see if your smartphone’s operating system is compatible**
*95% of the measured glucose values needed to fall within either ±15 mg/dL(±0.83 mmol/L) of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL(<5.55 mmol/L) or within ±15% at glucose concentrations ≥100 mg/dL(≥5.55 mmol/L). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
**On a compatible Android or iOS device. For a list of compatilbe devices, please visit compatibility.contourone.com
1. CONTOUR®NEXT ONE BGMS User Guide Rev 01/17.
2. Christiansen, M. P. (2017). A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology, 11(3), 567-573. DOI: 10.1177/1932296817691301.
3. International Organization for Standardization. In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013.
4. Richardson, J. et al. (2020) Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at Diabetes Technology Meeting (DTM) 2020. Maryland, USA.
The unique smartLIGHT feature makes it quicker and easier to interpret blood glucose readings using coloured lights that clearly identify if the reading is above, within or below your target range.*
Above Target Range
(Amber)
Within Target Range
(Green)
Below Target Range
(Red)
92% of users surveyed think it is quicker and easier to interpret their blood glucose readings using the smartLIGHT™ feature, compared to those that did not.1
A color range indicator may help improve HbA1c control compared to BGMs without a target range indicator2
Check to see if your smartphone’s operating system is compatible**
The smartLIGHT feature offers easier understanding of blood glucose readings.1
*Always consult your healthcare professional before setting or changing any target ranges.
**On a compatible Android or iOS device. For a list of compatilbe devices, please visit compatibility.contourone.com
1. Ascensia Diabetes Care. Data on File. Smartson Market Research study of the CNO meter and the CDA, (June 2017). Sweden. SMARTSON market research study of the CONTOUR® NEXT ONE meter and the CONTOUR® DIABETES app. Participants received a free meter and test strips. Smartson, http://business.smartson.com/
2. Grady, M. et al. (2018). Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients With Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study). Journal of Diabetes Science and Technology. DOI: 10.1177/1932296818775755.
Check to see if your smartphone’s operating system is compatible*
*Always consult your healthcare professional before setting or changing any target ranges.
1. CONTOUR®NEXT ONE BGMS User Guide Rev 01/17.
2. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.
Apple, Apple Health badge, and the Apple logo are trademarks of Apple Inc. App Store is a service mark of Apple Inc. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. Google Play and the Google Play logo are trademarks of Google LLC.